# EDWARDS LIFESCIENCES CORPORATION (EW) FY2025 Q1 P&L / Income Statement

- Company: EDWARDS LIFESCIENCES CORPORATION (EW)
- Period: 2025-01-01 to 2025-03-31
- Filing: Q1 FY2025 10-Q, filed 2025-05-06, accession number 0001099800-25-000023
- Page: https://plicit.ai/financials/ew/fy2025-q1-income-statement
- Chart image: https://plicit.ai/charts/ew-fy2025-q1-income-statement-sankey.png

## Chart details: Revenue by Product and Service

Income statement for 2025-01-01 through 2025-03-31. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 1,412,700,000 US dollars
- **Cost of sales**: 301,600,000 US dollars
- **Gross profit**: 1,111,100,000 US dollars
- **Operating costs, net of other operating income (calculated)**: 716,300,000 US dollars
- **Operating income, net**: 394,800,000 US dollars
- **Other income (expense), net (calculated)**: 39,100,000 US dollars
- **Income from continuing operations before provision for income taxes**: 433,900,000 US dollars
- **Provision for income taxes**: 70,300,000 US dollars
- **Net income**: 356,400,000 US dollars
- **Transcatheter Aortic Valve Replacement**: 1,046,600,000 US dollars
- **Transcatheter Mitral and Tricuspid Therapies**: 115,200,000 US dollars
- **Surgical Structural Heart**: 250,900,000 US dollars
- **Selling, general, and administrative expenses**: 465,700,000 US dollars
- **Research and development expenses**: 254,600,000 US dollars
- **Certain litigation expenses**: 10,900,000 US dollars
- **Separation costs (Note 3)**: 4,200,000 US dollars
- **Other operating income**: negative 19,100,000 US dollars
- **(Loss) income from discontinued operations, net of tax**: negative 7,200,000 US dollars. Reported below-tax contribution to net income.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.
- Of which attributable to EDWARDS LIFESCIENCES CORPORATION: $358.00 M; to noncontrolling interests: −$1.60 M.

## Chart details: Revenue by Business Segment

- Page: https://plicit.ai/financials/ew/fy2025-q1-income-statement/revenue-by-business-segment
- Chart image: https://plicit.ai/charts/ew-fy2025-q1-revenue-by-business-segment-sankey.png

Income statement for 2025-01-01 through 2025-03-31. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 1,412,700,000 US dollars
- **Cost of sales**: 301,600,000 US dollars
- **Gross profit**: 1,111,100,000 US dollars
- **Operating costs, net of other operating income (calculated)**: 716,300,000 US dollars
- **Operating income, net**: 394,800,000 US dollars
- **Other income (expense), net (calculated)**: 39,100,000 US dollars
- **Income from continuing operations before provision for income taxes**: 433,900,000 US dollars
- **Provision for income taxes**: 70,300,000 US dollars
- **Net income**: 356,400,000 US dollars
- **United States**: 838,900,000 US dollars
- **Europe**: 341,800,000 US dollars
- **Japan**: 81,800,000 US dollars
- **Rest of World**: 150,200,000 US dollars
- **Selling, general, and administrative expenses**: 465,700,000 US dollars
- **Research and development expenses**: 254,600,000 US dollars
- **Certain litigation expenses**: 10,900,000 US dollars
- **Separation costs (Note 3)**: 4,200,000 US dollars
- **Other operating income**: negative 19,100,000 US dollars
- **(Loss) income from discontinued operations, net of tax**: negative 7,200,000 US dollars. Reported below-tax contribution to net income.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.
- Of which attributable to EDWARDS LIFESCIENCES CORPORATION: $358.00 M; to noncontrolling interests: −$1.60 M.